Bladder Cancer - Results from #40

Bladder EpiCheck Urine Methylation Test and Photodynamic Diagnostic Cystoscopy for the Surveillance of High-Risk Non-Muscle-Invasive Bladder Cancer – Expert Commentary January 5, 2022

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis. January 5, 2022

Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis. January 5, 2022

Radical cystectomy for clinical T4b urothelial carcinoma: An Ontario, single-center experience. January 4, 2022

A systematic review and meta-analysis of neoadjuvant chemotherapy for bladder cancer between ddMVAC and GC regimen. January 4, 2022

Computational Prediction of Neoantigens in Patients with Urothelial Cancer - Expert Commentary January 3, 2022

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival January 3, 2022

Benchmarking PASADENA Consensus along the Learning Curve of Robotic Radical Cystectomy with Intracorporeal Neobladder: CUSUM Based Assessment. January 3, 2022

Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database. January 3, 2022

Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications. December 31, 2021

Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study. December 31, 2021

Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. December 30, 2021

Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve Block to Avoid Adductor Contractions during Transurethral Resection of Bladder Tumors. December 30, 2021

International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer. December 29, 2021

En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. December 29, 2021

Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer. December 28, 2021

Robot-assisted-radical-cystectomy with total intracorporeal Y neobladder: Analysis of postoperative complications and functional outcomes with urodynamics findings. December 28, 2021

Predictive factors of early postoperative complications after robot-assisted radical cystectomy for urothelial bladder carcinoma. December 27, 2021

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. December 27, 2021

Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer. December 24, 2021

Page 3 of 417

email news signup